Although GDF15 serum levels seem to provide a better prediction of mitochondrial disease regardless of clinical phenotype (with a diagnostic sensitivity of around 80% [28,29,30]), the small number of patients evaluated in our series prevents us from drawing conclusions about its diagnostic performance in patients with PEO syndrome. Here, GDF15 is linked to inborn mitochondrial metabolism disorder.